Blessing Ojika

Experienced hematologist specializing in hematological oncology and precision medicine. Proficient in diagnosing, managing, and treating various blood disorders and malignancies, including leukemias, lymphomas, myelomas, and sickle cell disease. Committed to delivering evidence-based care for superior patient outcomes. Passionate about integrating molecular medicine and precision diagnostic techniques to personalize treatments based on individual genetic profiles, environmental factors, and lifestyle considerations. Dedicated to implementing robust Quality Management Systems (QMS) for accurate and timely diagnoses, ensuring patient safety and high-quality care. Committed to mentoring aspiring hematologists and junior doctors to foster future healthcare leaders. Actively involved in prominent organizations such as the Nigerian Society of Haematology and Blood Transfusion, the African Organization for Research and Training in Cancer (AORTIC), and the African Cancer Coalition, contributing to the development of standardized cancer treatment protocols for Sub-Saharan Africa. Leading groundbreaking research and clinical trials as Principal Investigator for the Phase 1 Pociredr study on sickle cell disease and Study Coordinator for the AGIOS ARISE study, driving innovation for transformative treatments that enhance patient health and quality of life.

www.linkedin.com/in/blessing-ojika-6a871031/